Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.64 |
| ▸ | CA1 | P00915 | 4/20 | 0.64 |
| ▸ | CA2 | P00918 | 4/20 | 0.64 |
| ▸ | CA6 | P23280 | 4/20 | 0.64 |
| ▸ | CA9 | Q16790 | 4/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.64 |
| ▸ | CA4 | P22748 | 3/20 | 0.64 |
| ▸ | CA7 | P43166 | 3/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | LCK | P06239 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | KDM5A | P29375 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | CDC25B | P30305 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30579441 | 1.00 | CA12 (0.64) | CA12CA1CA2CA6CA9 | |
| SCHEMBL16494696 | 0.86 | KDM4E (0.53) | CA12CA1CA2CA6CA9 | |
| SCHEMBL28020171 | 0.81 | KDM4E (0.57) | CA12CA1CA2CA6CA9 | |
| SCHEMBL27913796 | 0.80 | CASP6 (0.62) | CA12CA1CA2CA6CA9 | |
| SCHEMBL31279968 | 0.80 | TSHR (0.58) | CA12CA1CA2CA6CA9 | |
| SCHEMBL29399562 | 0.80 | TSHR (0.58) | CA12CA1CA2CA6CA9 | |
| SCHEMBL17254441 | 0.80 | TSHR (0.58) | CA12CA1CA2CA6CA9 | |
| SCHEMBL9409009 | 0.79 | CA12 (0.54) | CA12CA1CA2CA6CA9 | |
| Protocatechuic Acid SCHEMBL39435 | 0.78 | CA12 (1.00) | CA12CA1CA2CA6CA9 | |
| Protocatechuic Acid SCHEMBL30030432 | 0.78 | CA12 (1.00) | CA12CA1CA2CA6CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113564224-A | Biomarkers for malignant transformation of submucosal fibrosis in oral cavity | 台达电子工业股份有限公司 | 2021-10-29 | — | — | CN | claimed |
| EP-4689191-A2 | METHODS OF CLASSIFYING AND TREATING INFLAMMATORY BOWEL DISEASE | Baylor College of Medicine (US) | 2026-02-11 | — | — | EP | disclosed |
| US-12357601-B2 | Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivative | NOSTER INC. (JP) | 2025-07-15 | — | — | US | disclosed |
| US-20250207207-A1 | TAXONOMIC SIGNATURES AND METHODS OF DETERMINING THE SAME | BAYLOR COLLEGE OF MEDICINE (US) | 2025-06-26 | — | — | US | disclosed |
| EP-4499878-A2 | TAXONOMIC SIGNATURES AND METHODS OF DETERMINING THE SAME | Baylor College of Medicine (US) | 2025-02-05 | — | — | EP | disclosed |
| CN-115954444-B | Preparation method of naphthalene polycarboxylate organic material and application of naphthalene polycarboxylate organic material in metal ion battery | 中国科学院深圳先进技术研究院 | 2025-01-14 | — | — | CN | disclosed |
| WO-2024206308-A2 | METHODS OF CLASSIFYING AND TREATING INFLAMMATORY BOWEL DISEASE | BAYLOR COLLEGE OF MEDICINE (US) | 2024-10-03 | — | — | WO | disclosed |
| US-11948662-B2 | Metabolite, annotation, and gene integration system and method | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-04-02 | — | — | US | disclosed |
| CN-110573150-B | Composition for inhibiting proliferation of bacteria having menaquinone synthesis pathway via furalosine or furalosine derivative | 内斯托尔株式会社 | 2024-02-27 | — | — | CN | disclosed |
| WO-2023192815-A2 | TAXONOMIC SIGNATURES AND METHODS OF DETERMINING THE SAME | BAYLOR COLLEGE OF MEDICINE (US) | 2023-10-05 | — | — | WO | disclosed |
| US-8653160-B2 | Inclusion complex containing epoxy resin composition for semiconductor encapsulation | NIPPON SODA CO., LTD. (JP) | 2014-02-18 | — | — | US | disclosed |
| EP-2573148-A1 | CURABLE POWDER COATING COMPOSITION, AND CURED PRODUCT OF SAME | Nippon Soda Co., Ltd. (JP) | 2013-03-27 | — | — | EP | disclosed |
| US-20130059942-A1 | CURABLE POWDER COATING COMPOSITION, AND CURED PRODUCT OF SAME | NIPPON SODA CO., LTD. (JP) | 2013-03-07 | — | — | US | disclosed |
| CN-102725273-A | Clathrate and method for producing same | NIPPON SODA CO | 2012-10-10 | — | — | CN | disclosed |
| CN-101802049-B | Epoxy resin composition for semiconductor encapsulation containing inclusion complex | NIPPON SODA CO | 2012-09-12 | — | — | CN | disclosed |
| EP-2489689-A1 | COMPOSITION FOR FORMATION OF CURED EPOXY RESIN, AND CURED PRODUCTS THEREOF | Nippon Soda Co., Ltd. (JP) | 2012-08-22 | — | — | EP | disclosed |
| US-20120196991-A1 | COMPOSITION FOR FORMATION OF CURED EPOXY RESIN, AND CURED PRODUCTS THEREOF | NISSO CHEMICAL ANALYSIS SERVICE CO., LTD. (JP) | 2012-08-02 | — | — | US | disclosed |
| CN-101802049-A | Epoxy resin composition for semiconductor encapsulation containing inclusion complex | NIPPON SODA CO | 2010-08-11 | — | — | CN | disclosed |
| US-20100179250-A1 | INCLUSION COMPLEX CONTAINING EPOXY RESIN COMPOSITION FOR SEMICONDUCTOR ENCAPSULATION | NIPPON SODA CO., LTD. (JP) | 2010-07-15 | — | — | US | disclosed |
| EP-2192139-A1 | INCLUSION COMPLEX CONTAINING EPOXY RESIN COMPOSITION FOR SEMICONDUCTOR ENCAPSULATION | Nippon Soda Co., Ltd. (JP) | 2010-06-02 | — | — | EP | disclosed |